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Abstract
Objective: Identifying predictors of infection or colonization with resistant microorganisms. 
Methods: A quantitative study of prospective cohort was carried out. A descriptive analysis was performed in 
order to know the population of the study and a discriminant analysis was performed to identify the predictors.
Results: In this study were included 85 patients with infections caused by resistant microorganisms: 
carbapenem-resistant Pseudomonas aeruginosas (24.7%); carbapenem-resistant Acinetobacter (21.2%); 
methicillin-resistant Staphylococcus aureus (25.9%), vancomycin-resistant Enterococcus spp (17.6%) and 
carbapenem-resistant Klebsiella pneumonia (10.6%). The discriminant analysis identified transfers from other 
hospitals and hospitalization in intensive care unit as predictors for the occurrence of infections by the following 
groups: S. aureus resistant to methicillin, Acinetobacter resistant to carbapenems and K. pneumoniae resistant 
to carbapenems. None of the studied variables was discriminant for vancomycin-resistant Enterococcus spp. 
and carbapenem-resistant P. aeruginosas.
Conclusion: The predictors found were: ICU hospitalization and transfers from other hospitals.
Resumo
Objetivo: Identificar os fatores preditores de infecção ou colonização por micro-organismos resistentes.
Métodos: Foi realizado estudo quantitativo de coorte prospectivo. Foram realizadas a análise descritiva, para 
conhecimento da população do estudo, e a análise discriminante, para identificação dos fatores preditores.
Resultados: Foram incluídos 85 pacientes com infecções por micro-organismos resistentes: Pseudomonas 
aeruginosas resistente aos carbapenêmicos (24,7%), Acinetobacter resistente aos carbapenêmicos (21,2%), 
Staphylococcus aureus resistente à meticilina (25,9%), Enterococcus spp. resistente à vancomicina (17,6%) 
e Klebsiella pneumoniae resistente aos carbapenêmicos (10,6%). A análise discriminante identificou 
transferências de outros hospitais e internação na Unidade de Terapia Intensiva como fatores preditores 
para ocorrência de infecção pelos grupos S. aureus resistente à meticilina, Acinetobacter resistente aos 
carbapenêmicos e K. pneumoniae resistente aos carbapenêmicos. Nenhuma das variáveis estudadas foi 
discriminante para Enterococcus spp. resistente à vancomicina e P. aeruginosas resistente aos carbapenêmico.
Conclusão: Os fatores preditores encontrados foram: internação na UTI e a transferências de outros hospitais. 
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Introduction
Infections related to healthcare caused by micro-
organisms resistant to multiple antimicrobials 
(MDRO, multidrug-resistant organisms) are in-
creasingly prevalent in hospitals. The severity and 
extent of the diseases caused by these pathogens 
varies according to the affected population and the 
institution in which they are found.(1) According 
to estimates from the European Center for Disease 
Prevention and Control (ECDC), the MDRO in-
fections affect one in every 20 hospitalized patients.
(2) The increased morbidity and mortality as a con-
sequence of these infections is directly related with 
the difficult treatment due to the limited availabili-
ty of effective drugs.(3)
The colonization or infection with resistant 
microorganisms in hospitalized patients has been 
receiving increasing attention from the services of 
hospital infection control.(4,5) The impact of this in-
fectious complications in the hospital environment 
turns into longer hospitalization, readmission, se-
quels, inability to work, cost increases and mortal-
ity. There are no accurate estimates for the global 
impact of these infections.(6)
Infections associated with health assistance con-
stitute an important problem worldwide and repre-
sent a major threat to the safety of patients.(7)
The Centers for Disease and Control and Pre-
vention (CDC) recommends the implementation 
of contact precautions for this population. Howev-
er, several studies show low adherence to such strat-
egy.(8-10) Besides, there is the risk of delay in the di-
agnosis of colonization or infection, which increases 
the possibilities of transmission among patients.
The virulence and transmissibility of some mi-
croorganisms has evidenced the inability of erad-
icating these agents, hence the need for searching 
new methods of control.(11) Studies show it is useful 
to perform epidemiological surveillance cultures to 
know the real extent of the resistance problem in 
healthcare facilities.(12)
Surveillance cultures must be performed in 
order to diagnose colonized or infected patients, 
who are a reservoir for dissemination of these mi-
croorganisms. The purpose of this collection is the 
early identification of MDRO colonized or infect-
ed patients and the immediate deploy of infection 
control strategies, reducing cross-contamination 
and the risk of developing subsequent infections.
(11) However, this practice is only strongly recom-
mended in outbreak situations, in endemic cases 
that are not controllable with protocol measures 
or in risk populations because surveillance cultures 
consume material and human resources and have 
high costs.(2) Moreover, the influx of MDRO colo-
nized patients does not change and there is a delay 
in obtaining culture test results, favoring the spread 
of these agents.
Experts recommend deploying contact precau-
tions with the predictors criterion(2,13) as a strategy 
to control MDRO dissemination. The objective of 
this study was to identify the predictors of infection 
or colonization with resistant microorganisms.
Methods
The selected design for the study was cohort, con-
ducted in a tertiary public school hospital which has 
979 beds for clinical and surgical treatment, located 
in São Paulo (SP). The Grupo Executivo de Con-
trole de Infecção Hospitalar, GECIH (Executive 
Group for Hospital Infection Control) develops the 
program of hospital infection control based on a 
methodology called National Nosocomial Infection 
Surveillance System (NNIS). (14)
Data collection was conducted between August 
2007 and January 2008 through active search, af-
ter the resistant microorganism was identified by 
the microbiology laboratory of the hospital, in 
accordance with conventional methods of bac-
terial isolation and identification. The researcher 
was notified of the positive result for surveillance 
culture and then conducted the follow-up with 
patients by filling up a special form until their dis-
charge or death. When the patient had more than 
one resistant microorganism, it was considered the 
first to be identified.
The demographic data collected were the ones 
cited in literature as risk factors for contracting 
MDRO: age, gender, origin, underlying disease, 
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date of hospital admission, length of hospital stay, 
antibiotic use, invasive procedures, surgical proce-
dures in the past 30 days, date of the infection relat-
ed to healthcare and its location, associated diseas-
es, previous hospitalization, admission to intensive 
care unit, contact with patients with MDRO and 
clinical evolution.(2,5)
MDROs were defined as: methicillin-resistant 
Staphylococcus aureus (MRSA); vancomycin-resis-
tant Enterococcus spp. (VRE); carbapenem-resistant 
Pseudomonas aeruginosa (PCR); carbapenem-re-
sistant Acinetobacter (ARC); carbapenem-resistant 
Klebsiella pneumoniae (KRC).
After collection data were processed using the 
Statistical Package for Social Science (SPSS), ver-
sion 17.0. Initially a descriptive analysis was carried 
out to know the population of the study. Afterwards 
a discriminant analysis was performed to identify 
the predictive factors.
The development of the study met both nation-
al and international ethical standards of research in-
volving human beings.
Results
During the study period all the patients with 
MDRO were included (n=85). The average age of 
patients with microorganisms was 68.7 years with a 
standard deviation of 16.4 (Table 1).
The MRSA, ARC and KRC groups showed 
equally predictive variables as follows: hospitaliza-
tion in intensive care units and transfers from other 
hospitals (Table 2). Data show that in the relation 
between the predictive variables and the ARC group 
there was a classification in 94.4% of cases while 
with the MRSA group it was 54.5% and with KRC 
group it was 44.4%. It is also noteworthy that none 
of the elements of the study with predictors was re-
lated with PCR and VRE.
Table 2 shows two discriminant functions. The 
second function best discriminates “transfers from 
other hospitals” as a predictor, while the first func-
tion best discriminates the “ICU hospitalization”. 
Data in table 3 show the best classification for 
the ARC group with 94.4% of accuracy, followed 
by the MRSA group with 54.5% and by the KRC 
group with 44.4% for the variables “transfers from 
other hospitals” and “ICU hospitalization”, identi-
fied as predictive factors. 
Discussion
This study was limited by the number of patients 
included and its conduction in an only healthcare 
center, which compromises the generalization of 
data.
The results of this study in relation to the resis-
tant microorganisms identified are similar to those 
in literature when compared to the population of 
ICU patients in other institutions. The prevalent 
resistant microorganisms found were: P. aeruginosa, 
Acinetobacter baumanni, S. aureus, K. pneumoniae 
and Enterobacter cloace.(15)
The prevalence of resistant microorganisms that 
frequently cause nosocomial infections is modi-
fied according to the study site, with rates between 
58 and 71% of PRC and between 43 and 59% of 
MRSA.(11,15) In this study however, prevalence of 
these agents was lower: 24.7% for PRC and 25.9% 
for MRSA.
Previous use of antimicrobial, prior hospitaliza-
tion and acute kidney injury are identified by sever-
al studies as risk factors for colonization with VRE.
(16,17)  Regarding the PRC, some studies have shown 
as predictors of colonization the following: presence 
of cancer, previous use of antimicrobial and surgery 
in the prior four weeks.(18,19)   In this study, none of 
these variables was discriminant for VRE and PRC, 
probably because of the sample size or due to in-
terference of extrinsic factors. Although this latter 
case was not studied the transmission of microbial 
agents among patients may have occurred.
Studies show previous use of antimicrobial and 
prior hospitalization as risk factors for MRSA col-
onization; for KRC they indicate the presence of 
cancer, ICU admission and use of antimicrobials; 
for ARC the presence of cancer, high APACHE II 
score, ICU admission and exposure to antimicro-
bials.(17,20-22)  In this study, through discriminant 
canonical function  coefficients of resistant micro-
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Table 1. Characteristics of patients colonized or infected with resistant microorganisms
Variables MRSA
n(%)
VRE
n(%)
PRC
n(%)
ARC
n(%)
KRC
n(%)
Gender
Male 11(50.0) 11(73.3) 9(42.8) 10(55.6) 5(55.6)
Origin
Transfer from other hospitals 2(9.1) - 1 (4.8) 1(5.6) 4(44.4)
Previous hospitalization in the past 30 days 9(40.9) 10(66.7) 8(38.1) 9(50.0) 3(33.3)
ICU hospitalization 10(45.4) 9 (60.0) 15(71.4) 18(100.0) 8(88.9)
Invasive procedures
Use of indwelling urinary catheter 12(54.5) 12(80.0) 15(71.4) 18(100.0) 9(100.0)
Use of central venous catheter 12(54.5) 12(80.0) 15(71.4) 18(100.0) 9(100.0)
Use of mechanical ventilation 11(50.0) 10(66.7) 13(61.9) 18(100.0) 9(100.0)
Surgery in the past 30 days 3(13.6) 2(13.3) 5(23.8) 3(16.7) 1(11.1)
Material
Catheter 1(4.5) 1(6.7) 1(4.8) 4(22.2) 1(11.1)
Blood 14(63.6) 13(86.7) 9(42.9) 7(38.9) 7(77.8)
Secretions 6(27.1) - 7(33.3) 6(33.4) 1(11.1)
Tendon 1(4.5) - 1(4.8) - -
Urine - 1(6.7) 3 (14.3) 1 (5.6) -
Diseases
Diabetes mellitus 12(54.5) 5(33.3) 4(19.1) 4 (22.2) 2 (22.2)
Neoplasia 1 (4.5) 1(6.7) 1(4.8) 2 (11.1) 1(11.1)
Chronic renal failure 3(13.6) 4(26.7) 4(19.1) 5 (27.8) 2(22.2)
Acute renal failure 4(18.2) 4(26.7) 3(14.3) 4 (22.2) 1(11.1)
Neurological disease 4(18.2) 5(33.3) 1(4.8) 1(5.5) 1(11.1)
Corticotherapy 5(22.7) 1(6.7) 2(9.52) 5(27.8) 1(11.1)
Type of infection
Urinary tract 3(16.7) 3(18.8) 8(27.6) 1(5.0) 3(33.3)
Wound 1(5.6) 2(12.5) 8(27.6) 6(30.0) -
Peritonitis - - 1(3.4) - -
Blood stream 4(22.2) 1 (6.3) 3(10.3) - -
Pneumonia 7(38.9) 10(62.5) 9(31.0) 12(60.0) 6(66.7)
Skin or soft tissue 1(5.6) - - 1(5.0) -
Abdominal focused 1(5.6) - - - -
Meningitis 1(5.6) - - - -
Evolution
Hospital discharge 10(45.4) 3(20.0) 10(47.6) 5(27.8) 1(11.1)
Death 12(54.5) 12(80.0) 11(52.4) 13(72.2) 8(88.9)
Total 22 (25.9) 15 (17.6) 21 (24.7) 18 (21.2) 9 (10.6)
Legend: MRSA – Staphylococcus aureus resistant to methicillin; VRE – Enterococcus spp. resistant to vancomycin; PCR – Pseudomonas aeruginosa  resistant to 
carbapenems; ARC  –  Acinetobacter resistant to carbapenems; KRC – Klebsiella pneumoniae resistant to carbapenems; ICU – intensive care unit
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organisms, transfers from other hospitals and ICU 
hospitalization were identified as predictive factors 
for positive culture for MRSA, ARC and KRC. 
Even antibiotics use, no matter what class studied, 
did not lead to the occurrence of a particular mi-
croorganism, suggesting that the selection promot-
ed by the use of broad-spectrum antimicrobials is 
homogeneous, regardless of resistance mechanism. 
Multiple predisposing factors have been linked 
to emergence and spread of resistant microorgan-
isms, such as declining age, length of hospital stay, 
severity of underlying disease, enteral feeding, trans-
fers between units and hospitals, surgeries, exposure 
to invasive procedures and use of antibiotics.(23)
The results of ICU admission as a predictor 
for MDRO positive culture are compatible with 
other studies. ICUs are places where many inva-
sive procedures take place and that concentrate the 
severest medical and surgical patients admitted in 
hospitals, with higher infection rates, which leads 
to a widespread use of antimicrobial, factors that 
contribute to the increase of nosocomial infections 
and bacterial resistance. Therefore, these units 
are the main source of resistant micro-organisms 
outbreaks. These patients are at increased risk for 
bloodstream infections, pneumonia and urinary 
tract infection, having different microorganisms as 
etiologic agents.(24,25) Thus, ICUs are the epicenter 
of MDRO infections, which can be disseminated 
throughout the hospital. Yet, another challenge is 
to control the spread outside the hospital environ-
ment, in other words, the community, in long stay 
institutions or in other places of patients transfers 
after hospital discharge.(5)
In this study transfers from other hospitals were 
found as predictors for colonization or infection 
with MDROs, a factor previously shown in other 
studies. Patients transferred from other hospitals 
or who have stayed more than 24 hours in anoth-
er hospital for examinations or procedures may be 
colonized or infected with resistant microorganisms 
and, upon entering the institution, may show clini-
cal infection by the agent or transmit it horizontally.
Infection control practices have arisen over the 
years, to prevent the spread of infections by epide-
miologically important microorganisms. Great part 
of researches by the Society of Healthcare Epide-
miology of America (SHEA) has been highlighted 
in the guidelines of infection. Practical guidelines 
include contact precautions for MDRO infected 
patients, sterile barrier precautions during imple-
mentation of central venous catheter, hand hygiene 
with alcoholic solutions, surveillance and routine 
precautions for MRSA and VRE in areas where 
high risk patients are hospitalized.(26)
Thus, patients transferred from other hospitals 
should be kept in contact precautions in order to 
take cultures of invasive devices, lesion and rectal 
swab. Infected and colonized patients should remain 
in precaution until discharge. For patients who had 
contact with colonized or infected patients it is also 
recommended to take cultures of invasive devices, 
lesions and rectal swab. ICU colonized or infected 
patients must remain in contact precautions until 
discharge and when transferred to the hospitaliza-
tion unit should remain isolated until the end of 
treatment, in cases of infection or colonization.(1)
Table 2. Canonical discriminant function coefficients of 
resistant microorganisms
Predictive factors
Function
1 2
Transfers from other hospitals 2.119 3.015
ICU hospitalization 1.818 -1.538
(Constant) -1.482 0.802
Legend: Discriminant analysis was used to identify predictors. ICU – intensive 
care unit
Table 3. Classification results of resistant microorganisms
Group
MRSA
n(%)
VRE
n(%)
PRC
n(%)
ARC
n(%)
KRC
n(%)
Total
MRSA 12(54.5) 0(0.0) 0(0.0) 8(36.4) 2(9.1) 22(100.0)
VRE 6(40.0) 0(0.0) 0(0.0) 9(60.0) 0(0.0) 15(100.0)
PRC 6(28.6) 0(0.0) 0(0.0) 14(66.7) 1(4.8) 21(100.0)
ARC 0(0.0) 0(0.0) 0(0.0) 17(94.4) 1(5.6) 18(100.0)
KRC 0(0.0) 0(0.0) 0(0.0) 5(55.6) 4(44.4) 9(100.0)
Legend: Discriminant analysis was used to classify the resistant 
microorganisms. MRSA – methicillin-resistant Staphylococcus aureus; VRE 
– vancomycin-resistant Enterococcus spp.; PCR – carbapenem-resistant 
Pseudomonas aeruginosa; ARC – carbapenem-resistant Acinetobacter; KRC – 
carbapenem-resistant Klebsiella pneumoniae
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The early implementation of contact precau-
tions is extremely important to contain the spread 
of resistant microorganisms in healthcare envi-
ronments. The high cost of culture tests together 
with the delay in obtaining results make the iden-
tification of predictor variables, as in this study, a 
valuable tool.(1)
Conclusion
The predictive variables for colonization or infec-
tion with MRSA, ARC and KRC found in this 
study were transfers from other hospitals and ICU 
hospitalization. None of the variables studied was 
discriminant for colonization or infection with 
VRE and PCR.
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